The DOI matches its Crossref record, with a small difference in title or year.
Listing practices for morbidly obese patients at liver transplantation centers in the United States
Abstract
OBJECTIVES: The effect of morbid obesity on liver transplant outcomes has yielded mixed results. The aim of this study was to determine listing practices for morbidly obese patients at liver transplant centers in the United States. MATERIALS AND METHODS: A 19-item survey was created to assess liver transplant evaluation and listing practices for morbidly obese patients. All adult liver transplant medical and surgical directors in the United States were contacted by e-mail, which provided an Internet link to an online survey. RESULTS: We sent a total of 187 surveys by e-mail, with responses received from 46 physicians (24.7% response rate). A policy on evaluation and listing of obese patients was present at 70.5% of institutions, with most (54.5%) reporting that their body mass index cutoff for transplant was 40 kg/m2, but a range of 35 kg/m2 to unlimited was noted. Most respondents agreed that patients with high body mass index were less likely to be evaluated for transplant. Respondents reported increased complication rates among obese patients, with the most common being poor wound healing and increased infection rates. CONCLUSIONS: Most medical and surgical liver transplant directors have a strong appreciation of the possible morbidity risks associated with performing liver transplants in morbidly obese patients and have policies in effect to minimize these risks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the impact of obesity on overall and graft survival is controversial, 493 candidates for liver transplantation with obesity have higher waitlist mortality and lower transplant rates, 494 and are less likely to be evaluated for liver transplantation. 495”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [495]
Citations
Cites
Still being checked.
Research works printed but not linked: 14
- 10.1001/jama.295.13.1549 · DOI · Paper page
- 10.1001/archinte.163.18.2146 · DOI
- 10.1016/S1542-3565(04)00440-9 · DOI
- 10.1002/lt.20738 · DOI
- 10.3748/wjg.v20.i42.15532 · DOI
- 10.1016/S1072-7515(97)00109-9 · DOI
- 10.1097/SLA.0b013e3181ad8935 · DOI
- 10.1111/j.1600-6143.2007.02100.x · DOI
- 10.1002/lt.22155 · DOI
- 10.1053/j.gastro.2014.11.039 · DOI
- 10.1002/hep.26986 · DOI
- 10.1097/SLA.0b013e31818a01ef · DOI · Paper page
- 10.1053/jhep.2002.30318 · DOI
- 10.1111/j.1600-6143.2012.04318.x · DOI
Cited by
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Metadata
- Authors
- Marzio, D. H., Wong, S.-Y., Fenkel, J. M., Doria, C., & Sass, D. A.
- Affiliations
- Thomas Jefferson University (US)
- Venue
- Experimental and Clinical Transplantation
- Publisher
- Baskent University
- Published
- 2016-12
- Volume
- 14
- Issue
- 6
- Pages
- 646-649
- ISSN
- 1304-0855 (ISSN-L)
- 2146-8427
- OpenAlex
- W641014242
- Cited by
- 15
- References
- 0
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2016: 3
- Type
- paratext
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- morbid obesity, liver transplantation, body mass index cutoffs, transplant evaluation, wound complications, infection rate, transplant policy
- MeSH terms
- Female, Humans, Length of Stay, Liver Diseases, Male, Obesity, Morbid, United States, Body Mass Index, Survival Rate, Liver Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.